Bessemer Group Inc Amgen Inc Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Amgen Inc stock. As of the latest transaction made, Bessemer Group Inc holds 47,045 shares of AMGN stock, worth $12.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

47,045

Previous 45,952 2.38%

Holding current value

$12.4 Million

Previous $14.4 Million 5.56%

% of portfolio

0.02%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $338,152 - $368,756	1,093 Added 2.38%	47,045 $15.2 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $2.3 Million - $2.79 Million	8,750 Added 23.52%	45,952 $14.4 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $2.27 Million - $2.74 Million	8,441 Added 29.35%	37,202 $10.6 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $449,520 - $507,112	1,758 Added 6.51%	28,761 $8.29 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $533,943 - $662,905	2,442 Added 9.94%	27,003 $7.26 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $61,924 - $73,223	-289 Reduced 1.16%	24,561 $5.45 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $165,504 - $201,721	733 Added 3.04%	24,850 $6.01 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $589,752 - $749,350	-2,575 Reduced 9.65%	24,117 $6.34 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $377,092 - $425,292	1,680 Added 6.72%	26,692 $6.02 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $175,801 - $195,635	762 Added 3.14%	25,012 $6.08 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $603,869 - $668,037	2,754 Added 12.81%	24,250 $5.86 Million
Q4 2021 Jan 27, 2022	SELL	$198.88 - $227.6 $55.3 Million - $63.3 Million	-277,933 Reduced 92.82%	21,496 $4.84 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $29.8 Million - $34.9 Million	-140,451 Reduced 31.93%	299,429 $63.7 Million
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $4.46 Million - $4.94 Million	19,082 Added 4.53%	439,880 $107 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $7.94 Million - $9.25 Million	35,758 Added 9.29%	420,798 $105 Million
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $65,995 - $78,589	-305 Reduced 0.08%	385,040 $88.5 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $8.39 Million - $9.33 Million	35,756 Added 10.23%	385,345 $97.9 Million
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $1.4 Million - $1.71 Million	7,056 Added 2.06%	349,589 $82.5 Million
Q1 2020 Apr 30, 2020	BUY	$182.24 - $241.7 $201,557 - $267,320	1,106 Added 0.32%	342,533 $69.4 Million
Q4 2019 Feb 04, 2020	SELL	$189.21 - $243.2 $2.3 Million - $2.95 Million	-12,137 Reduced 3.43%	341,427 $82.3 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $298,598 - $357,783	1,715 Added 0.49%	353,564 $68.4 Million
Q2 2019 Jul 19, 2019	BUY	$166.7 - $195.41 $18.2 Million - $21.3 Million	108,994 Added 44.88%	351,849 $64.8 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $1.31 Million - $1.48 Million	7,251 Added 3.08%	242,855 $46.1 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $30.1 Million - $35.2 Million	168,912 Added 253.27%	235,604 $45.9 Million
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $1.81 Million - $2.04 Million	9,749 Added 17.12%	66,692 $13.8 Million
Q2 2018 Jul 25, 2018	SELL	$166.05 - $186.51 $1.33 Million - $1.5 Million	-8,032 Reduced 12.36%	56,943 $10.5 Million
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $599,273 - $700,326	3,537 Added 5.76%	64,975 $11.1 Million
Q4 2017 Jan 30, 2018	SELL	$168.79 - $188.59 $8,945 - $9,995	-53 Reduced 0.09%	61,438 $10.7 Million
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $10.3 Million - $11.7 Million	61,491	61,491 $11.5 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

407M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Amgen Inc Transaction History